Option chain shows key data for Lotus Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Lotus Pharma.

Lotus Pharma (OTC:LTUS) Stock, Option Chain

Lotus Pharmaceuticals is a development stage company.

News

LTUS

Lotus Pharmaceuticals Announces New Patent for Diabetes Drug 

LOTUS PHARMS INC by Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals

<p>Lotus Pharmaceuticals, Inc. (LTUS) announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. </p>
<p>The patent covers the composition and preparation methods for the drug through 2030.</p>


Comments

Lotus Pharma

Lotus Pharma (LTUS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga